US EditionPublished • loading... • Updated
PTC Therapeutics (NASDAQ:PTCT) VP Sells $171,196.30 in Stock
Summary by watchlistnews.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
PTC Therapeutics (NASDAQ:PTCT) VP Sells $171,196.30 in Stock
PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) VP Mark Elliott Boulding sold 2,266 shares of the business’s stock in a transaction dated Monday, January 5th. The stock was sold at an average price of $75.55, for a total transaction of $171,196.30. Following the transaction, the vice president owned 120,901 shares in the company, valued […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
